Cite
Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial
MLA
Butler, J.Filippatos, G.Jamal Siddiqi, T.Brueckmann, M.Böhm, M.Chopra, V. K.Pedro Ferreira, J.Januzzi, J. L.Kaul, S.Piña, I. L.Ponikowski, P.Shah, S. J.Senni, M.Vedin, O.Verma, S.Peil, B.Pocock, S. J.Zannad, F.Packer, M.Anker, S. D. Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial. Jan. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2127..aca95c2c04cb5d6753e3c029f22a45ab&authtype=sso&custid=ns315887.
APA
Butler, J. F. G. J. S. T. B. M. B. M. C. V. K. P. F. J. J. J. L. K. S. P. I. L. P. P. S. S. J. S. M. V. O. V. S. P. B. P. S. J. Z. F. P. M. A. S. D. (2022). Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial.
Chicago
Butler, J. Filippatos, G. Jamal Siddiqi, T. Brueckmann, M. Böhm, M. Chopra, V.K. Pedro Ferreira, J. Januzzi, J.L. Kaul, S. Piña, I.L. Ponikowski, P. Shah, S.J. Senni, M. Vedin, O. Verma, S. Peil, B. Pocock, S.J. Zannad, F. Packer, M. Anker, S.D. 2022. “Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2127..aca95c2c04cb5d6753e3c029f22a45ab&authtype=sso&custid=ns315887.